Clinical Trials Directory

Trials / Unknown

UnknownNCT01118884

Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide for Uncooperative Children

Sedative Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide/Oxygen on Behavior Management of Uncooperative Children Receiving Dental Treatment

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Shahid Beheshti University · Academic / Other
Sex
All
Age
36 Months – 96 Months
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the safety and efficacy of sedation using orally administered midazolam and promethazine with nitrous oxide/oxygen in uncooperative children receiving dental treatments.

Detailed description

The effectiveness of oral midazolam in pediatric dentistry is controversial. Usefulness of midazolam alone is limited to short-duration procedures, and we are needed to identify safe oral conscious regiments which permit longer duration procedures in dental treatments especially in Pediatric dentistry. Promethazine is a long-acting (4-12 hr) anti-histaminic, H1 antagonist drug which acts as a central nervous system depressant and showing itself to be a weak anxiolytic drug. The hypothesis to be tested is whether promethazine would improve the patients behavior during dental procedures without affecting vital signs, thus enabling longer periods of moderate or conscious sedation.

Conditions

Interventions

TypeNameDescription
DRUGPromethazineSyrup ,1 mg/kg, oral , 30 minutes before dental procedure , its duration is 4-6 hours

Timeline

Start date
2009-06-01
Primary completion
2010-04-01
Completion
2010-05-01
First posted
2010-05-07
Last updated
2010-05-07

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01118884. Inclusion in this directory is not an endorsement.